Like the Pfizer and Moderna vaccines, the COVID-19 vaccine candidate being developed by the mid-cap biotech featured in today’s article uses a messenger RNA (mRNA)… Read More »Is This One-Dose mRNA COVID Vaccine Stock A Must-Buy?
Today’s article details two stocks that, according to both analysts at JPMorgan as well as the broader Wall Street analyst consensus, are primed for strong… Read More »2 Stocks Where Analysts See Strong Gains Ahead
“Very few people have gotten rich on their seventh best idea, but a lot of people have gotten rich with their best idea,” Warren Buffett… Read More »Big-Name Money Managers Are Making Big Bets On These 2 “Best Idea” Stocks
In compiling its “Imagine 2025” portfolio, analysts at RBC Capital Markets sought to identify companies “they felt were positioning most boldly and effectively for the… Read More »The Tech Stocks Positioned To “Own The Future”
When discussing stocks, the author of today’s article, John Dorfman of Dorfman Value Investments, typically does not focus on stocks that he – and most… Read More »A Money Manager Breaks Convention And Reveals The 24 Stocks He – And Most Of His Clients – Own
One study identified them as “the most powerful force impacting stock prices”: earnings estimate revisions. As the author of today’s article states, “That means stocks… Read More »5 Cheap Stocks With Rising Earnings Estimates
Out of the nearly 5,000 analysts tracked by the website TipRanks, the five who give their top stock picks for 2018 in today’s article have… Read More »Top Stock Picks For 2018 From Wall Street’s Most Profitable Analysts
Today’s article highlights several cheap stocks that could be big winners – with the author noting that cheap stocks “are the ones that have been… Read More »Cheap, Profitable & Growing: 5 Stocks Under $5 That Could Be Big Winners